Two-year safety and effectiveness of hybrid ablation versus catheter ablation in patients with non-paroxysmal AF: mid-term results of the CEASE-AF trial

Back

EHRA Premium Access

Two-year safety and effectiveness of hybrid ablation versus catheter ablation in patients with non-paroxysmal AF: mid-term results of the CEASE-AF trial

Session: Atrial fibrillation: treatment 2

Topic: Rhythm Control, Hybrid Therapy

Speaker: Doctor M. Wijffels (Nieuwegein, NL)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Doctor Maurits Wijffels

St Antonius Hospital, Nieuwegein (Netherlands (The))

0 follower

8 more presentations in this session

Hybrid ablation versus repeated catheter ablation in persistent atrial fibrillation: long-term results of the HARTCAP-AF trial.

Speaker: Ms C. van der Heijden (Maastricht, NL)

Long-term outcomes in hybrid versus standalone thoracoscopic ablation in patients with atrial fibrillation: a systematic review and reconstructed individual patient data meta-analysis.

Speaker: Miss L. Aerts (Maastricht, NL)

Intra-procedural three-dimensional rotational angiography in cryoballoon ablation of atrial fibrillation - results from a randomised clinical trial

Speaker: Doctor I. Prepolec (Zagreb, HR)

The hybrid ablation approach to treating long-standing persistent atrial fibrillation: real-world data from a tertiary institution

Speaker: Doctor V. Lim (Coventry, GB)

LINAC-Based STereotactic Arrhythmia Radioablation (STAR) for paroxysmal atrial fibrillation in elderly: a prospective phase II trial

Speaker: Doctor I. Romanazzi (Acquaviva Delle Fonti, IT)

Access the full session

Atrial fibrillation: treatment 2

Speakers: Doctor M. Wijffels, Ms C. van der Heijden, Miss L. Aerts, Doctor I. Prepolec, Doctor V. Lim...

Access

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources